(Yicai Global) Sept. 12 -- An artificial intelligence medical applications developer, Shenrui Medical Co., which was established only a few months ago, recently completed its CNY35 million (USD5.3 million) first-round financing, online media outlet jiemian.com reported without naming the investors.
Shenrui Medical is an AI medical applications developer, mainly covering medical imaging recognition, early screening of various malignant diseases, accurate diagnostic solutions and other fields. The first medical imaging diagnostic system for early lung cancer screening completed by the team led by company's founder Lei Ming has been tested at several large hospitals in the country.
With medical imaging equipment screening results improving, using AI technology for medical image preliminary diagnosis has become a new hot investment area for AI entrepreneurs. Domestic internet giants have also entered the field, with the first medical screening AI product introduced earlier by Tencent Holdings Ltd. [HK:0700] and the medical AI system ‘Doctor You’ released by Alibaba Group Holding Ltd [NYSE:BABA] and its partners.Keywords: FINANCING, AI, Cancer Diagnosis, Medical Applications